{"id":5460,"date":"2022-05-06T06:00:00","date_gmt":"2022-05-06T04:00:00","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-therapeutics-anlitar-lago-kapital-ab-som-likviditetsgarant\/"},"modified":"2022-05-06T06:00:00","modified_gmt":"2022-05-06T04:00:00","slug":"stayble-therapeutics-anlitar-lago-kapital-ab-som-likviditetsgarant","status":"publish","type":"cision-feed","link":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-therapeutics-anlitar-lago-kapital-ab-som-likviditetsgarant\/","title":{"rendered":"Stayble Therapeutics anlitar Lago Kapital AB som likviditetsgarant"},"content":{"rendered":"<p style=\"margin-bottom:0pt;margin-top:12px\"><span style=\"font-family:arial,helvetica,sans-serif;font-size:9pt\">Lago kommer att s\u00e4kerst\u00e4lla m\u00f6jligheten att handla i Stayble aktien noterad p\u00e5 Nasdaq First North Growth Market genom att kontinuerligt st\u00e4lla handelsposter p\u00e5 vardera k\u00f6p- och s\u00e4ljsida i orderboken. Detta \u00e4r i enlighet med Nasdaq Stockholms regelverk kring likviditetsgaranti. Avtalet \u00e4r bindande i sex (6) m\u00e5nader varefter de fortl\u00f6per med en m\u00e5nads upps\u00e4gningstid. Syftet med likviditetsgaranti \u00e4r att s\u00e4kerst\u00e4lla likviditet i aktien och att minska skillnaden mellan k\u00f6p- och s\u00e4ljkurs under p\u00e5g\u00e5ende handel. <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stayble Therapeutics AB (\u201dStayble\u201d eller \u201dBolaget\u201d) meddelar idag att Bolaget kommer med start fr\u00e5n den 9 maj 2022 att byta likviditetsgarant till Lago Kapital AB (\u201dLago\u201d). Stayble har sagt upp sitt nuvarande avtal g\u00e4llande likviditetsgaranti med Mangold Fondkommission AB.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5460"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/cision-feed"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5460"}],"version-history":[{"count":0,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5460\/revisions"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}